Antipodean Advisors LLC
- SEC CIK
- 0001512566
- Latest filing
- Nov 14, 2023
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 8
- 0 vs. Q1 2023
- Portfolio value
- $14.1M
- −$2.06M (−12.8%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SESea Ltd | SPONSORD ADS | 70,000 | $4.06M | 28.8% | 00.0% | Unchanged | History |
| OXYOccidental Petroleum Corp | Stock | 55,000 | $3.23M | 22.9% | +55,000 | New | History |
| VanEck ETF Trust92189F106 | GOLD MINERS ETF | 75,000 | $2.26M | 16.0% | 00.0% | Unchanged | – |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,000,000 | $1.61M | 11.4% | 00.0% | Unchanged | History |
| CMAXCareMax, Inc. | COM CL A | 425,000 | $1.32M | 9.4% | 00.0% | Unchanged | History |
| Investment Managers Ser Tr I46144X867 | AXS TSLA BEAR DL | 35,000 | $1.13M | 8.0% | −40,000−53.3% | Reduced | – |
| CVNACarvana Co. | CL A | 10,000 | $259.2K | 1.8% | 00.0% | Unchanged | History |
| CDLXCardlytics, Inc. | COM | 35,000 | $221.2K | 1.6% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (1)
Positions held at the end of Q1 2023 that are gone from this filing.